Our newest advisory board member, Nureddin Ashammakhi, PhD, was visiting our LA office for a strategy and brainstorming day. Dr. Ashammakhi is a great addition to our Company’s 3D bioprinting application strategy team, and his knowledge in personalized medicine which is one of our key application protocols.
Nureddin Ashammakhi, MD, Ph.D.
Sr. Advisor, Faculty, Michigan State University, USA
Worlds leading researcher for the development of novel clinical solutions in the areas of biomaterials, 3D bioprinting and organ-on-a-chip for the development of regenerative therapeutics and personalized medicine.
